Endocrinology & Metabolism Newsletter

Dear Colleagues,

The Section of Endocrinology and Metabolism greeted 2025 with continued advances in research, education, and patient care. I want to share a few statistics to highlight the ongoing expansion of our patient care mission. At the end of the calendar year, we were on track for an annual 8% increase in work RVUs, which continues a remarkable five-year increase of 66% in RVUs generated by our section. Of course, RVUs are not a perfect metric of patient care, and the increase represents both an increase in the number of clinical endocrinologists in our section as well as a significant increase in the amount of work that each individual clinician is doing. This is also reflected in the dramatic expansion of the ambulatory practice across the entire Department of Internal Medicine over the same time frame. We are very busy, yet the demand for our services is increasing faster than our capacity to keep up. This is a testament to the expertise of our endocrinologists and the great care that they deliver. The section owes them all a hearty thanks for their wonderful work as outstanding practitioners.

In addition to providing outstanding patient care, since our last newsletter, we have continued to ask and answer important questions about diabetes, obesity, and osteoporosis, to name just a few areas. We have explored numerous connections, including the interface between metabolism and cardiovascular health. Our dedication to pushing forward the boundaries of our knowledge of endocrinology and metabolism helps our own patients and those across the world. These efforts are underscored in the articles that follow.

As our first-year fellows settle in and our second- and third-year fellows hit their stride, we welcome two new fellows who will join us later in 2025. Furthermore, we are proud that Dr. Guy Sydney (see highlight below), one of our current first-year fellows, was selected for the competitive Investigative Medicine Program at YSM and will enroll in the Yale Graduate School of Arts and Sciences to work towards his PhD, as he embarks on the research component of his endocrinology fellowship in July. He plans to work with Dr. Kevan Herold to study the immunology of T1D. Great work, Guy.

I am honored to work alongside such talented faculty, staff, and trainees. I hope you enjoy reading some of their stories.

Sincerely,

John Wysolmerski, MD
Professor of Medicine (Endocrinology)
Section Chief, Endocrinology & Metabolism
Department of Internal Medicine, Yale School of Medicine